Swiss pharmaceuticals giant hopes to lower its overall headcount worldwide to below 100,000, from about 126,000 today.
Intense discussions continue but stalling over dispute settlement mechanism.
Enhances manufacturing capabilities and export capacity.
Company to transfer North American production of Xifaxan and Apriso to Steinbach facility.
Pharmaceutical firm’s lawyer cites an absence of an easily defined class of complainants.
Makers accused of misleading the public about remedy’s short-term effectiveness.
Trade deal stalled over next-gen pharmaceuticals that delayed resolution of other issues.
Online pharmacy based in Winnipeg accused of smuggling, money laundering and conspiracy.
Analysts says delaying the arrival of cheaper generic drugs will add up to 13%.
Suit to involve makers of the drug, Abbott Laboratories and generic manufacturer Apotex.
European Chamber of Commerce in China says accusations get more publicity from state-controlled media.
Conference Board of Canada, BDC report says companies are looking for new markets
Canadian manufacturers in key industry sectors are waiting for their customers to fully recover from the recession before consistent growth will occur, says a Conference Board of Canada report.